Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.
Scanlan MJ, Ritter G, Yin BW, Williams C Jr, Cohen LS, Coplan KA, Fortunato SR, Frosina D, Lee SY, Murray AE, Chua R, Filonenko VV, Sato E, Old LJ, Jungbluth AA.
Scanlan MJ, et al. Among authors: coplan ka.
Cancer Immun. 2006 Jan 12;6:2.
Cancer Immun. 2006.
PMID: 16405301